FIELD: pharmacology.
SUBSTANCE: invention relates to the field of medical chemistry and pharmacology, namely to new quaternary ammonium salts, specifically to derivatives of 5,7-dimethyl-1,3-diazaadamantan containing monoterpenoid fragments, general formula 1, including spatial isomers, particularly optically active forms, where X: CO, CH2, C = NOH, and Z can be a halogen or a nitro group having an actoprotective effect.
EFFECT: the actoprotective effect of 5,7-dimethyl-1,3-diazaadamantan derivatives of formula 1.
1 cl, 3 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 5,7-DIMETHYL-1,3-DIAZAADAMANTAN-6-ONE DERIVATIVES CONTAINING MONOTERPENE RESIDUE, NOVEL ANALGESIC AGENTS | 2014 |
|
RU2564446C1 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF (S)-N-[4-(1-ADAMANTYL)BENZOYL]-α-AMINO ACIDS AND SYNTHESIS METHOD THEREOF | 2009 |
|
RU2417988C2 |
| AGENT FOR INHIBITING HUMAN ENZYME TYROSYL-DNA-PHOSPHODIESTERASE 1 BASED ON PHENYLCOUMARINES, SENSITIZING TUMORS TO ANTITUMOUR AGENTS | 2019 |
|
RU2724878C1 |
| AMIDES WHICH COMBINE ADAMANTANE AND MONOTERPENE FRAGMENTS USED AS ORTHOPOXVIRUS INHIBITORS | 2019 |
|
RU2712135C1 |
| N-HETARYL-SUBSTITUTED 4-HYDROXY-1-METHYL-2,2-DIOXO-1H-2λ,1-BENZOTHIAZINE-3-CARBOXAMIDES, EXHIBITING ANALGESIC ACTIVITY | 2013 |
|
RU2544853C1 |
| DIETHYL 2,2-DIALKYLMALONATE AND 2,2-DIALKYL-1,3-DIMETHOXYPROPANE, CONTAINING 6,6-DIMETHYLBICYCLO[3.1.1]HEPTANE FRAGMENT OF NATURAL ORIGIN, METHOD FOR PRODUCTION THEREOF AND TITANIUM-MAGNESIUM CATALYST FOR POLYMERIZATION OF PROPYLENE CONTAINING THESE COMPOUNDS IN ITS COMPOSITION | 2023 |
|
RU2819723C1 |
| PYRIDOXINE DERIVATIVES WITH ANTICHOLINESTERASE ACTIVITY | 2014 |
|
RU2550080C1 |
| CHIRAL MYRTANYL SULPHONAMIDES | 2019 |
|
RU2725878C1 |
| FLUORATED 4-FURFURYL-3,4-DIHYDRO-2H-BENZO[1,4]THIAZINE-1,1-DIOXIDES WITH HIGH ARRYTHMIC ACTIVITY | 2016 |
|
RU2626239C1 |
| MEANS FOR HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME INHIBITION | 2015 |
|
RU2612875C1 |
